Market Entry - Adjuvant Industry in Malaysia: Analysis of Growth, Trends and Progress (2020 - 2025)

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Malaysia is a southeast Asian country with a democratic constitutional monarchy government. It is the fifth largest recipient of FDI in Asia with most of the investment in the manufacturing, finance, mining and distribution sectors. Malaysia has 16 bilateral trade agreements, is a part of ASEAN and WTO, and is currently negotiating a Malaysia-European Free Trade Agreement.

Malaysia is located close to major Asia-Pacific markets and companies investing in Malaysia find it a cost-effective gateway to Asian markets. It has a well-developed financial sector, English-speaking majority, educated workforce, and follows high standards of business and legal practices. The government has a provided many incentives to encourage FDI like liberalizing expatriate employment regime and MSC program, which was launched in 2003 to extend tax exemption from 10-15 years for new technology companies and from 5-10 years for priority companies. It has not been able to generate more foreign investments due to bureaucracy, shortage of skilled workers, and the governments’ policies favoring indigenous Malaysians.

A strong financial sector, developed infrastructure, significant resources, competitive costs, and liberal and transparent investment policies make Malaysia an ideal destination for foreign investment.

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.